Global Health Limited (Medanta) | Globe Capital
Global Health Limited (Medanta)
Closed
Price Band
Rs.319-336
IPO Issue Period
Nov 03, 2022 to Nov 07, 2022
Issue Size
Rs. 2205.57 Cr.
Face value
Rs. 2/-
Fresh issue
500Cr.
Offer for sale
1,705.57 Cr.
Minimum Shares for Retail
44 shares
Listing on
NSE, BSE
Issue Type
Book Building
Registrar to the Issue
KFin Technologies Limited
Tentative Listing Date
Nov 16, 2022
QIB
Not More than 50% of the offer
NII
Not less than 15% of the offer
Retail
Not less than 35% of the offer

Kotak Mahindra Capital Company Limited
Credit Suisse Securities (India) Private Limited
Jefferies India Private Limited
JM Financial Consultants Private Limited

Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.

Global Health Limited have a network of four hospitals currently in operation (Gurugram, Indore, Ranchi and Lucknow) under the “Medanta” brand. The company established “The Medanta Institutional Tissue Repository” in 2017 to promote biomarker and other tissue-based research.

In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, the company generated income from healthcare services of Rs. 14,805.71 million, Rs. 14,178.41 million, Rs. 21,003.95 million, Rs. 4,732.10 million and Rs. 5,960.89 226 million, respectively, and had EBITDA of Rs. 2,304.54 million, Rs. 2,228.52 million, Rs. 4,897.57 million, Rs. 1,057.69 million and Rs. 1,416.46 million, respectively.

As of June 30, 2022, the company provide healthcare services in over 30 medical specialities and engage over 1,300 doctors led by experienced department heads, spanning an area of 4.7 million sq. ft., the operational hospitals have 2,467 installed beds.

Global Health Limited’s hospital at Gurugram was ranked as the best private hospital in India for three consecutive years in 2020, 2021 and 2022, and was the only Indian private hospital to be featured in the list of top 200 global hospitals in 2021 and was featured in the list of top 250 global hospitals in 2022 by Newsweek

For year/ period ended ( in Cr.)

H1FY22 FY21 FY20
Total Revenue 2,166.59 1,446.74 1,500.42
Profit After Tax 196.20 28.81 36.33
EPS 7.78 1.15 1.45
OPM (%) 12.95% 2.24% 4.26%
PATM (%) 9.06% 1.99% 2.42%

 

  • It is well recognised for clinical expertise in particular in dealing with complicated cases.
  • Focus on Clinical Research and Academics
  • ‘Doctor-led’ hospitals driven by skilled and experienced doctors in the healthcare space
  • Track record of strong operational and financial performance
  • Focus on under-served areas with dense population and presence in top or capital cities of large states (NCR, Lucknow and Patna
  • 1. Repayment/prepayment of borrowings, in full or part, of the Subsidiaries, GHPPL and MHPL.2. General corporate purposes.

Global Health is operating under the most popular healthcare brand “Medanta” and posted growth over the years in its scale of operations. The issue is attractively priced based on its financial data and well compares with listed peers. Hence, Investors may subscribe to the Issue

Open Account